2022 - Research.com Medicine in Taiwan Leader Award
2022 - Research.com Microbiology in Taiwan Leader Award
Hepatitis B virus, Immunology, Virology, Hepatitis B and Internal medicine are his primary areas of study. His Hepatitis B virus study incorporates themes from Liver disease, Hepatocellular carcinoma and Genotype. Jia-Horng Kao usually deals with Hepatocellular carcinoma and limits it to topics linked to Hepatitis and Coinfection.
His Hepatitis B study frequently links to related topics such as Incidence. His Internal medicine study combines topics in areas such as Gastroenterology and Pegylated interferon, Ribavirin, Hepatitis C virus. Jia-Horng Kao focuses mostly in the field of Hepatitis C, narrowing it down to topics relating to Epidemiology and, in certain cases, Global health.
His primary areas of investigation include Internal medicine, Virology, Hepatitis B virus, Immunology and Gastroenterology. His Internal medicine research integrates issues from Ribavirin and Hepatitis C virus. His work carried out in the field of Hepatitis C virus brings together such families of science as Coinfection, Hepatitis C and Antibody.
His work in Virology is not limited to one particular discipline; it also encompasses Genotype. Jia-Horng Kao has researched Hepatitis B virus in several fields, including Liver disease and Hepatitis B. The various areas that he examines in his Gastroenterology study include Chronic hepatitis, Adverse effect, Hazard ratio, Confidence interval and Entecavir.
His main research concerns Internal medicine, Gastroenterology, Hepatitis C virus, Hepatocellular carcinoma and Hepatitis B virus. Jia-Horng Kao studied Internal medicine and Ribavirin that intersect with Coinfection. His Gastroenterology research includes elements of Chronic hepatitis, Pibrentasvir, Viral load, Glecaprevir and Confidence interval.
His Hepatitis C virus study integrates concerns from other disciplines, such as Hepatitis C, Genotype and Renal function. His biological study spans a wide range of topics, including Meta-analysis, Hepatitis B, Intensive care medicine and Risk factor. His HBsAg study is concerned with Immunology in general.
Jia-Horng Kao spends much of his time researching Internal medicine, Gastroenterology, Hepatitis C virus, Hepatitis B virus and Hepatitis C. He frequently studies issues relating to Ribavirin and Internal medicine. Jia-Horng Kao combines subjects such as Viral hepatitis and Hepatology with his study of Hepatitis C virus.
His Hepatitis B virus research includes themes of Risk factor, Hepatitis and Intensive care medicine. His work in Hepatitis C addresses issues such as Cirrhosis, which are connected to fields such as Propensity score matching, Population study and Discontinuation. His Hepatitis B research entails a greater understanding of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas.
Hepatology International (2016)
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Jia-Horng Kao;Pei-Jer Chen;Ming-Yang Lai;§ Ding-Shinn Chen‡.
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.
Yun-Fan Liaw;Nancy H. L. Leung;Jia-Horng Kao;Teerha Piratvisuth.
Hepatology International (2008)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
Yun Fan Liaw;Jia Horng Kao;Teerha Piratvisuth;Henry Lik Yuen Chan.
Hepatology International (2012)
Global control of hepatitis B virus infection
Jia-Horng Kao;Ding-Shinn Chen.
Lancet Infectious Diseases (2002)
Hepatitis B genotypes and the response to interferon therapy.
Jia-Horng Kao;Nan-Hui Wu;Pei-Jer Chen;Ming-Yang Lai.
Journal of Hepatology (2000)
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Ming-Whei Yu;Shiou-Hwei Yeh;Pei-Jer Chen;Yun-Fan Liaw.
Journal of the National Cancer Institute (2005)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Jia–Horng Kao;Pei–Jer Chen;Ming–Yang Lai;Ding–Shinn Chen.
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.
Yun-Fan Liaw;Nancy Leung;Richard Guan;George K.K. Lau.
Liver International (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: